Antibodies to peptides that target git receptors and related methods
CA 2347700 A1 · Owner: Seveso, Michela · Inventors: Seveso, Michela; O'Mahony, Daniel Joseph
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides an antibody or antibody fragment specific to a domain of a GIT targeting agent, such as a polyclonal antibody monoclonal antibody, chimeric antibody single chain antibody, a Fab fragment or a Fab expression library. In particular, the invention provides an antibody or antibody fragment, wherein the GIT targeting agent is selected from the group consisting of Zelan033 (PAX2 15 mer), Zelan088(HAX42-2 20 mer) or Zelan053 (P31 D-form 16 mer). Numerous methods using these GIT targeting agent specific antibodies are disclosed.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 19, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 19, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 19, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.